Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

37.420
+1.9405.47%
Volume:25.85M
Turnover:952.85M
Market Cap:226.58B
PE:35.33
High:37.660
Open:36.400
Low:35.920
Close:35.480
52wk High:44.220
52wk Low:19.601
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:2.50
T/O Rate:0.43%
Dividend:0.37
Dividend Rate:0.98%
EPS(LYR):1.059
ROE:17.35%
ROA:9.34%
PB:5.62
PE(LYR):35.33
PS:13.24

Loading ...

Hansoh Pharmaceutical Group Stock Climbs 4.6% in Hong Kong

Dow Jones
·
Mar 27

Hansoh Pharma presents phase 1b dalmelitinib plus aumolertinib data in MET-amplified NSCLC; median PFS rises to 7.4 months

Reuters
·
Mar 27

Merck braces for Keytruda patent loss with $6.7 billion Terns bet

Reuters
·
Mar 25

Hansoh Pharmaceutical Group Stock Sheds 1.5% in Hong Kong

Dow Jones
·
Mar 25

HANSOH PHARMA Achieves Top MSCI ESG Rating of AAA

Deep News
·
Mar 24

Hansoh Pharmaceutical Group Stock Slides 4.2% in Hong Kong

Dow Jones
·
Mar 23

HANSOH PHARMA's Novel Drug HS-10587 Tablets Receive Clinical Trial Approval from NMPA

Stock News
·
Mar 23

Hansoh Pharma Secures NMPA Clearance to Begin Clinical Trials for HS-10587 in MTAP-Deleted Advanced Solid Tumors

Bulletin Express
·
Mar 23

Hansoh Pharma Secures NMPA Approval to Begin Clinical Trials for HS-20152 Injection Targeting Paroxysmal Nocturnal Hemoglobinuria

Bulletin Express
·
Mar 23

Hansoh Pharmaceutical Wins NMPA Approval to Start HS-20152 Injection Clinical Trial for PNH

Reuters
·
Mar 23

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-10587 Tablets Issued by Nmpa China

THOMSON REUTERS
·
Mar 23

China NMPA grants clinical trial approval for Hansoh HS-10587 tablets

Reuters
·
Mar 23

Hansoh Pharmaceutical Group Stock Slides 1.5% in Hong Kong

Dow Jones
·
Mar 20

Hansoh Pharma (03692) Sets 29 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express
·
Mar 18

Hansoh Pharmaceutical to Hold Board Meeting to Approve Annual Results and Final Dividend

Reuters
·
Mar 18

China's Biopharma Sector Expected to Receive More Government Support -- Market Talk

Dow Jones
·
Mar 18

Hansoh Pharmaceutical Group Stock Advances 1.3% in Hong Kong

Dow Jones
·
Mar 17

Hansoh Pharmaceutical Group Stock Slides 2.7% in Hong Kong

Dow Jones
·
Mar 13

Hansoh Pharmaceutical Group Stock Slips 1.5% in Hong Kong

Dow Jones
·
Mar 11

BUZZ-Regeneron rises after announcing positive trial data on weight-loss drug

Reuters
·
Mar 10